S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creating an environment for tissue recovery. It also provides Symbiovance, a peptide-based functional skincare; Eyracure, a light-activated peptide technology that repairs damaged hair at the molecular level; and Eiratex, a biosynthetic polymer for wound healing applications. In addition, the company distributes instaQrett; skin substitutes under the EPIPROTECT brand; and BIOPAD, an ivory-white soft sponge. The company was incorporated in 2013 and is headquartered in Linköping, Sweden.
Frequently asked questions
What sector does S2Medical AB (S2M) operate in?
S2Medical AB belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is S2Medical AB (S2M) current stock price?
As of the latest data, S2Medical AB stock price is SEK 0.01, with a previous close of SEK 0.01.
What is S2Medical AB (S2M) current market capitalization?
S2Medical AB market cap is approximately 5.39 million.
What is S2Medical AB (S2M) Earnings Per Share (EPS)?
The trailing EPS is -SEK 0.02.
Does S2Medical AB (S2M) pay dividends?
No. S2Medical AB does not pay a dividend.
What is S2Medical AB (S2M) beta (volatility) score?
S2Medical AB has a beta of 2.297, indicating very high volatility compared to the market.
